why choose us

First received: April 06, 2023

Clinical Trial: Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Endometrial Cancer

Study Type: INTERVENTIONAL


Official Title: Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Brief Summary: To learn if chemotherapy given in combination with radiation therapy, followed by maintenance therapy, can help to control endometrial cancer.The safety and effects of this study treatment will also be studied

Read more